SGK1-Sensitive Regulation of Cyclin-Dependent Kinase Inhibitor 1B (p27) in Cardiomyocyte Hypertrophy
Background/Aims: The serum- and glucocorticoid-inducible kinase SGK1 participates in the orchestration of cardiac hypertrophy and remodeling. Signaling linking SGK1 activity to cardiac remodeling is, however, incompletely understood. SGK1 phosphorylation targets include cyclin-dependent kinase inhib...
Main Authors: | Jakob Voelkl, Tatsiana Castor, Katharina Musculus, Robert Viereck, Sobuj Mia, Martina Feger, Ioana Alesutan, Florian Lang |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2015-09-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/430380 |
Similar Items
-
Sgk1-Dependent Stimulation of Cardiac Na+/H+ Exchanger Nhe1 by Dexamethasone
by: Jakob Voelkl, et al.
Published: (2013-07-01) -
SGK1 in Cancer: Biomarker and Drug Target
by: Jonas Cicenas, et al.
Published: (2022-05-01) -
Serum and Glucocorticoid-Inducible Kinase 1 (SGK1) in NSCLC Therapy
by: Ilaria Guerriero, et al.
Published: (2020-11-01) -
SGK1, the New Player in the Game of Resistance: Chemo-Radio Molecular Target and Strategy for Inhibition
by: Cristina Talarico, et al.
Published: (2016-10-01) -
Discovery of Herbacetin as a Novel SGK1 Inhibitor to Alleviate Myocardial Hypertrophy
by: Shujing Zhang, et al.
Published: (2022-01-01)